Richard Pikner

545 total citations
34 papers, 275 citations indexed

About

Richard Pikner is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Richard Pikner has authored 34 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Molecular Biology. Recurrent topics in Richard Pikner's work include Thyroid Disorders and Treatments (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Bone health and osteoporosis research (4 papers). Richard Pikner is often cited by papers focused on Thyroid Disorders and Treatments (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Bone health and osteoporosis research (4 papers). Richard Pikner collaborates with scholars based in Czechia, Belgium and Australia. Richard Pikner's co-authors include Otto Mayer, L Holubec, Jaroslav Šimon, Štěpán Kutílek, Ondřej Topolčan, Étienne Cavalier, Masakazu Miura, Samuel D Vasikaran, Harjit Pal Bhattoa and Jan Filipovský and has published in prestigious journals such as Clinical Chemistry, Calcified Tissue International and European Journal of Clinical Pharmacology.

In The Last Decade

Richard Pikner

27 papers receiving 262 citations

Peers

Richard Pikner

ONCOL

EDM

OSM

SURGE

Subashini C. Thambiah Malaysia

Ran Cui China

Merja B. Marttunen Finland

Stamatios Kioufis Greece

Katrine B. Whitaker United Kingdom

Brian Durham United Kingdom

Hugh Taggart United Kingdom

Shelley Pallan Canada

Shengjue Xiao China

Evelyn Alonzo Venezuela

Subashini C. Thambiah Malaysia

Richard Pikner

57 ×0.7

ONCOL

46 ×0.6

EDM

65 ×0.9

98 ×2.1

OSM

72 ×1.6

SURGE

Citations per year, relative to Richard Pikner Richard Pikner (= 1×) peers Subashini C. Thambiah

Countries citing papers authored by Richard Pikner

Since Specialization

Citations

This map shows the geographic impact of Richard Pikner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Pikner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Pikner more than expected).

Fields of papers citing papers by Richard Pikner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Pikner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Pikner. The network helps show where Richard Pikner may publish in the future.

Co-authorship network of co-authors of Richard Pikner

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Pikner. A scholar is included among the top collaborators of Richard Pikner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Pikner. Richard Pikner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cavalier, Étienne, Harjit Pal Bhattoa, Annemieke C. Heijboer, et al.. (2025). Assessment of measurement uncertainty of immunoassays and LC-MS/MS methods for serum 25-hydroxyvitamin D. Clinical Chemistry and Laboratory Medicine (CCLM). 63(10). 1981–1991. 2 indexed citations

Lombardi, Giovanni, Niklas Rye Jørgensen, Nicholas C. Harvey, et al.. (2024). Guidelines for the correct use of the nomenclature of biochemical indices of bone status: a position statement of the Joint IOF Working Group and IFCC Committee on Bone Metabolism. Clinical Chemistry and Laboratory Medicine (CCLM). 63(4). 704–711. 3 indexed citations

Pikner, Richard, et al.. (2021). Fracture Liaison Services: Program for coordinated secondary prevention of osteoporotic fractures. 26(3). 119–132.

Pikner, Richard, et al.. (2021). Q-OSTEOPOROSIS: the comprehensive program for an assessment of healthcare quality at patients with risk of osteoporotic fractures. 26(3). 113–118.

Vasikaran, Samuel D, Masakazu Miura, Richard Pikner, Harjit Pal Bhattoa, & Étienne Cavalier. (2021). Practical Considerations for the Clinical Application of Bone Turnover Markers in Osteoporosis. Calcified Tissue International. 112(2). 148–157. 44 indexed citations

Pikner, Richard, et al.. (2020). Definice osteoporotické (křehké) zlomeniny: stanovisko Společnosti pro metabolická onemocnění skeletu České lékařské společnosti J. E. Purkyně (SMOS ČLS JEP). 25(2). 83–84. 1 indexed citations

Pikner, Richard, et al.. (2020). Bone turnover markers in osteoporosis: a common statement on their use of the Society for Metabolic Bone Diseases within the Czech Medical Association of J.E. Purkyne (SMBD CzMA JEP) and the Czech Society of Clinical Biochemistry within the Czech Medical Association of J.E. Purkyne (CSCB CzMA JEP). 25(2). 65–82.

Kutílek, Štěpán, et al.. (2019). Calcemia and Inflammatory Markers in Early-Onset Neonatal Infection. Acta Medica (Hradec Kralove Czech Republic). 62(2). 58–61. 7 indexed citations

Hořák, Pavel, et al.. (2018). Long-term denosumab therapy for osteoporosis and its interruption: expert opinion of the Society for Metabolic Bone Diseases working group within the Czech Medical Association of J.E. Purkyně. 23(1). 32–37.

10.

Kutílek, Štěpán, et al.. (2018). Three cases of transient neonatal pseudohypoparathyroidism. PubMed. 18(2). 42–47. 2 indexed citations

11.

Glattre, Eystein, et al.. (2009). Blood serum level of TSH and thyroid hormones and thyroid tissue content of iodine in rats under restricted selenium and iodine supply. Norsk Epidemiologi. 11(2). 1 indexed citations

12.

Mayer, Otto, et al.. (2008). Even mild changes in free thyroxine could influence the degree of heart failure measured by its biological surrogates. Physiological Research. 57(4). 525–529. 8 indexed citations

13.

Cibulka, Roman, et al.. (2007). Effect of L-Carnitine Supplementation on Secondary Hyperparathyroidism and Bone Metabolism in Hemodialyzed Patients. Calcified Tissue International. 81(2). 99–106. 8 indexed citations

14.

Eybl, V., Dana Kotyzová, Ondřej Topolčan, et al.. (2007). Effects of selenium and tellurium on the activity of selenoenzymes glutathione peroxidase and Type I iodothyronine deiodinase, trace element thyroid level, and thyroid hormone status in rats. Biological Trace Element Research. 117(1-3). 105–114. 9 indexed citations

15.

Mayer, Otto, et al.. (2006). Folate co-administration improves the effectiveness of fenofibrate to decrease the lipoprotein oxidation and endothelial dysfunction surrogates. Physiological Research. 55(5). 475–481. 15 indexed citations

16.

Mayer, Otto, et al.. (2006). Hypothyroidism in coronary heart disease and its relation to selected risk factors. Vascular Health and Risk Management. 2(4). 499–506. 37 indexed citations

17.

Holubec, L, Ondřej Topolčan, Jindřich Fínek, et al.. (2005). Markers of cellular adhesion in diagnosis and therapy control of colorectal carcinoma.. PubMed. 25(3A). 1597–601. 11 indexed citations

18.

Mayer, Otto, et al.. (2004). Fibrate treatment and prevalence risk of mild hyperhomocysteinaemia in clinical coronary heart disease patients. European Journal of Cardiovascular Prevention & Rehabilitation. 11(3). 244–249. 4 indexed citations

19.

Mayer, Otto, Jaroslav Šimon, L Holubec, Richard Pikner, & Ivan Šubrt. (2003). Fenofibrate-induced hyperhomocysteinemia may be prevented by folate co-administration. European Journal of Clinical Pharmacology. 59(5-6). 367–371. 25 indexed citations

20.

Pecen, Ladislav, et al.. (2002). Predicting Response of Ovarian Cancer to Paclitaxel Treatment Based on Trend Analysis of Serum CA125. Clinical Chemistry. 48(8). 1364–1367. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact